Trade Ironwood Pharmaceuticals Inc - IRWD CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.03
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.022262 %(-$0.45)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: -0.02226%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00004 %($0.00)Trade size with leverage ~ $2,000.00Money from leverage ~ $$1,000.00Go to platform: 0.00004%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.022262 %
  (-$0.45)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00004 %
  ($0.00)

Key Stats

• Prev. Close: 3.74
• Open: 3.76
• 1-Year Change: 164.79%
• Day's Range: 3.76 - 3.76

Trade Ironwood Pharmaceuticals Inc - IRWD

Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) is a biopharmaceutical company specializing in the development and commercialization of treatments for gastrointestinal (GI) diseases. Best known for its leading drug, LINZESS®, which treats irritable bowel syndrome and chronic constipation, the company focuses on advancing innovative GI therapies. Through continued research and strategic partnerships, Ironwood remains dedicated to improving patient outcomes in gastroenterology.